Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Purchase |
2025-02-05 4:17 pm |
MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO |
50,000 | $10.69 | $534,500 | 1,172,674 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Option Award |
2025-02-05 4:17 pm |
N/A 2035-02-03 |
MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO |
243,000 | $0 | 1,172,674 (Direct) |
View |
| 2024-09-16 Conversion |
2024-09-17 8:07 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO |
5,205,750 | $0 | 879,674 (Direct) |
View |
| 2024-09-12 Option Award |
2024-09-13 5:06 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO |
120,436 | $0 | 120,436 (Direct) |
View |
Ownership |
2024-09-12 7:34 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO |
0 | $0 | 1,910,632 (Direct) |
View |